AstraZeneca Says Its Blood Thinner No Better Than Aspirin

The drugmaker said Brilinta was no more effective than aspirin at preventing major heart problems in stroke patients, denting the company’s growth ambitions for one of its key drugs.

from WSJ.com: US Business http://ift.tt/1WIib96
via IFTTT